Sign in to continue:

Wednesday, February 25th, 2026

CION Investment Corp 8-K Filing February 24, 2026 – Executive Resignation, Company Details, and Security Information




CION Investment Corporation – Financial Reporter Analysis

CION Investment Corporation (NYSE: CION) – Key Executive Departure Announced

Summary of Key Points

  • Executive Resignation: On February 24, 2026, Charlie Arestia, Managing Director and Head of Investor Relations at CION Investment Corporation and its investment adviser, CION Investment Management, LLC, tendered his resignation to pursue other career opportunities.
  • Report Type: The company filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC), signaling a material event.
  • Security Information:
    • Common Stock (par value \$0.001 per share) listed on NYSE under ticker CION
    • 7.50% Notes due 2029 listed under ticker CICB on NYSE
    • 7.50% Notes due 2031 listed under ticker CICC on NYSE
  • Emerging Growth Company Status: CION is not considered an emerging growth company.

Shareholder Considerations & Potential Price Sensitivity

  • Executive Departure:

    The departure of Charlie Arestia, who served as Managing Director and Head of Investor Relations, is a significant change in leadership. Investor Relations is a critical function, especially for a public business development company (BDC) like CION, as it shapes the communication with shareholders, analysts, and the broader market. His resignation may prompt questions about the company’s investor engagement strategy and whether any transition plans are in place.

    Leadership changes at this level can be viewed as price-sensitive, particularly if investors perceive uncertainty regarding communication, transparency, or capital markets activities. While the filing states he left to pursue other opportunities, shareholders should monitor for any further announcements on his replacement or changes to investor relations processes.

  • No Other Material Events Disclosed:

    The Form 8-K does not report any financial statements, material transactions, or changes in business operations aside from the resignation. There are no disclosures relating to pre-commencement tender offers, written communications, or soliciting materials under SEC rules.

  • Regulatory Compliance:

    CION confirms compliance with all SEC reporting requirements and is not involved in bankruptcy proceedings or shell company events. Its securities remain listed on the NYSE, and no amendments to previously filed reports were indicated.

  • Potential Impact on Share Price:

    The news of a key executive departure, especially from the Investor Relations function, could affect investor sentiment and potentially impact share price in the short term. Investors may anticipate updates regarding succession, potential changes in communication strategy, or impacts on capital raising activities.

Detailed Security Information

Security Ticker Exchange
Common Stock, par value \$0.001 per share CION NYSE
7.50% Notes due 2029 CICB NYSE
7.50% Notes due 2031 CICC NYSE

Corporate Signatories

The Form 8-K was signed by Michael A. Reisner, Co-Chief Executive Officer of CION Investment Corporation, indicating official company approval and oversight.

Conclusion

Investors should pay close attention to leadership changes, especially in functions critical to shareholder engagement and market communications. While no immediate financial or operational changes are disclosed, the resignation of a senior executive may signal upcoming announcements or shifts in how the company interacts with stakeholders. Monitoring future filings or press releases for updates on succession or investor relations strategy is advised.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. The information is based on publicly available filings as of February 24, 2026. Investors should conduct their own due diligence and consult a professional advisor before making investment decisions related to CION Investment Corporation or any securities mentioned herein.




View CION Investment Corp Historical chart here



Corcept Therapeutics Provides Update on Patent Dispute With Teva Pharmaceuticals Over Korlym Generic – Court Rules No Infringement

Key Points from the Report Federal Court Ruling: The United States Court of Appeals for the Federal Circuit has upheld a previous verdict that Teva Pharmaceuticals’ marketing of a generic version of Korlym® does...

ContextLogic Holdings Inc. Files Form 8-K Current Report with SEC – Company Details, Address, and Filing Information (February 2026) 3 4 5

ContextLogic Holdings Inc. Announces Expiration of Rights Offering ContextLogic Holdings Inc. Announces Expiration of Rights Offering Date: February 23, 2026 Key Points from the Report The rights offering subscription period for ContextLogic Holdings Inc....

VSee Health, Inc. Enters Managed Services and $2 Million Stock Purchase Agreements with GoMyRx – SEC 8-K Filing Details

VSEE Health, Inc. Files Form 8-K: Stock Purchase Agreement and Key Company Updates VSEE Health, Inc. (NASDAQ: VSEE), an emerging growth company, has filed a Form 8-K with the Securities and Exchange Commission (SEC),...

   Ad